{"id":"W2749878693","doi":"10.1200/jco.2017.35.15_suppl.4003","title":"KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Tolerability; Cohort; Internal medicine; Cancer; Discontinuation; Oncology; Gastroenterology; Surgery; Adverse effect; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001045224,0.0001646565,0.001716603,0.0001750514,0.0000543454,0.00001104478,0.0002201637,0.0001722442,0.00006805953],"category_scores_gemma":[0.001027624,0.0001080052,0.0001764399,0.0001171208,0.000249529,0.0001604815,0.00005518061,0.0005050212,8.382826e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001876081,"about_ca_system_score_gemma":0.0005273567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001241175,"about_ca_topic_score_gemma":0.0001437267,"domain_scores_codex":[0.9973387,0.000143579,0.001717564,0.0002144114,0.0003420438,0.0002436668],"domain_scores_gemma":[0.9959389,0.0005567623,0.002644471,0.0003228,0.0003158689,0.0002211824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04203042,0.0007047398,0.70985,0.00003103889,0.0003115234,0.0000552034,0.00002957002,0.00003321464,0.000004729208,0.000005918477,0.000195644,0.246748],"study_design_scores_gemma":[0.0794871,0.01361683,0.9016749,0.0002509411,0.0004145323,0.00001234803,0.00001237532,0.00002415367,0.00000717584,0.00001251303,0.004407324,0.00007985227],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957132,0.0004026953,0.00004547299,0.001766263,0.0003200421,0.0006398159,0.000003231019,0.000005481568,0.001103751],"genre_scores_gemma":[0.9935871,0.004498838,0.001024623,0.0003954683,0.0001881944,0.000005962112,0.000002311868,0.00001772186,0.0002797938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2466682,"threshold_uncertainty_score":0.4404323,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04503207699257356,"score_gpt":0.4131629942430535,"score_spread":0.36813091725048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}